HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Guillaume Taieb Selected Research
Guillaume Taieb Research Topics
Disease
5
Inflammation (Inflammations)
01/2021 - 08/2011
4
Demyelinating Diseases (Demyelinating Disease)
01/2023 - 03/2016
3
Polyneuropathies (Polyneuropathy)
01/2022 - 07/2017
2
Encephalitis (Encephalitis, Rasmussen)
01/2023 - 05/2020
2
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2023 - 01/2022
2
Vasculitis (Vasculitides)
01/2023 - 01/2011
2
Transverse Myelitis (Necrotizing Myelitis)
01/2023 - 10/2015
2
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2022 - 01/2017
2
Posterior Leukoencephalopathy Syndrome
05/2020 - 03/2016
2
Lymphoma (Lymphomas)
01/2019 - 03/2016
1
cell-associated neurotoxicity
01/2023
1
Polyradiculoneuropathy (Polyradiculoneuritis)
01/2023
1
Histiocytosis
01/2023
1
Hyponatremia
01/2023
1
Meningitis
01/2023
1
Systemic Vasculitis
01/2023
1
Radiculopathy (Radiculopathy, Cervical)
01/2023
1
Paraneoplastic Syndromes (Paraneoplastic Syndrome)
01/2023
1
Cytokine Release Syndrome
01/2023
1
Stroke (Strokes)
01/2023
1
Hematologic Neoplasms (Hematological Malignancy)
01/2023
1
Connective Tissue Diseases (Connective Tissue Disease)
01/2023
1
POEMS Syndrome (Syndrome, POEMS)
01/2023
1
Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
06/2022
1
Membranous Glomerulonephritis (Membranous Nephropathy)
12/2021
1
Lupus Nephritis
12/2021
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021
1
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2021
1
Hypertension (High Blood Pressure)
05/2020
1
Immune Reconstitution Inflammatory Syndrome
05/2020
1
Acquired Immunodeficiency Syndrome (AIDS)
05/2020
1
Gender Dysphoria
05/2020
1
Paraplegia (Spastic Paraplegia)
01/2019
1
Atrophy
05/2017
1
Susac Syndrome
03/2016
1
Wounds and Injuries (Trauma)
03/2016
1
Infections
03/2016
1
Progressive Multifocal Leukoencephalopathy
11/2014
1
Tremor (Tremors)
04/2011
1
Polyarteritis Nodosa (Periarteritis Nodosa)
01/2011
Drug/Important Bio-Agent (IBA)
5
Steroids
IBA
01/2021 - 08/2011
4
Antibodies
IBA
06/2022 - 10/2015
3
Autoantibodies
IBA
01/2022 - 07/2017
2
Gadolinium
IBA
01/2023 - 01/2021
2
Proteins (Proteins, Gene)
FDA Link
01/2023 - 12/2021
2
Biomarkers (Surrogate Marker)
IBA
10/2022 - 07/2017
2
Antigens
IBA
12/2021 - 08/2016
1
Glial Fibrillary Acidic Protein
IBA
01/2023
1
Intravenous Immunoglobulins (IVIG)
FDA Link
01/2023
1
C-Reactive Protein
IBA
01/2023
1
Chimeric Antigen Receptors
IBA
01/2023
1
Therapeutic Uses
IBA
10/2022
1
Riluzole
FDA Link
Generic
10/2022
1
Immunoglobulin G (IgG)
IBA
01/2022
1
Contactin 1
IBA
12/2021
1
Testosterone (Sustanon)
FDA Link
05/2020
1
Prednisolone (Predate)
FDA Link
Generic
01/2019
1
Prednisone (Sone)
FDA Link
Generic
01/2019
1
Glycoproteins (Glycoprotein)
IBA
01/2019
1
Myelin-Associated Glycoprotein
IBA
01/2019
1
Protein Isoforms (Isoforms)
IBA
07/2017
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
05/2017
1
Superoxide Dismutase-1
IBA
01/2017
1
Natalizumab (Tysabri)
FDA Link
11/2014
1
Facilitative Glucose Transport Proteins (Glucose Transporter)
IBA
04/2011
1
Antigen-Antibody Complex (Immune Complex)
IBA
01/2011
Therapy/Procedure
1
Therapeutics
05/2020
1
Injections
05/2020
1
Chemoradiotherapy
03/2016